What it is
BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide whose sequence corresponds to a fragment associated with a protein found in human gastric juice. It is widely discussed in the research and biohacking communities but is not an approved drug and is generally sold for laboratory research purposes only.
What researchers are studying
- Promotion of angiogenesis (new blood-vessel formation) in injured tissue, as investigated in animal models.
- Modulation of growth-factor and nitric-oxide pathways associated with tissue repair.
- Interaction with the gut–brain axis and gastrointestinal mucosal protection reported in rodent studies.
Areas studied
- Tendon, ligament and muscle healing (preclinical)
- Gastrointestinal mucosal protection and ulcer models (preclinical)
- Wound healing and angiogenesis (preclinical)
Evidence summary
Human research
Direct, peer-reviewed human clinical trial evidence for BPC-157 is currently very limited. Most claims circulating online extrapolate from animal studies. Because well-controlled human trials are scarce, conclusions about efficacy or long-term safety in people cannot be drawn from the existing literature.
Preclinical & animal research
The majority of BPC-157 research consists of rodent (rat/mouse) studies exploring tendon-to-bone healing, gut ulcer models, and vascular repair. These preclinical findings are frequently cited but have not been confirmed by large human trials, and animal results do not reliably predict human outcomes.
Limitations & uncertainties
- Human clinical data is sparse; most evidence is preclinical.
- Many studies originate from a limited number of research groups.
- Purity, sourcing, and dosing in community use are unregulated and highly variable.
Safety & research considerations
BPC-157 is not approved by regulatory agencies for human use, and its long-term safety profile in humans has not been established through controlled trials. Product purity is not guaranteed in the unregulated market. This page does not provide dosing guidance.
Frequently asked questions
- Is BPC-157 approved for medical use?
- No. BPC-157 is an investigational research compound and is not approved as a medicine by the FDA or comparable agencies. It is generally sold for research purposes only.
- Is BPC-157 supported by human studies?
- Current research is overwhelmingly preclinical (animal-based). Robust, peer-reviewed human clinical trial evidence is very limited, so efficacy in people remains unestablished.
References & further reading
Curated literature searches on PubMed and clinical-trial registries. A formal, per-study citation list is being expanded during ongoing editorial review.